Adlai Nortye Ltd. (ANL)
NASDAQ·Healthcare·Biotechnology
$12.08
-4.85%
Mkt Cap $274.57M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
Implied Upside
+115.3%
Consensus $26.00 vs current $12.08
NASDAQ·Healthcare·Biotechnology
$12.08
-4.85%
Mkt Cap $274.57M
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
+115.3%
Consensus $26.00 vs current $12.08